Related Experiment Video
Updated: Feb 7, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT
Ernestina M De Francesco1,2, Marcello Maggiolini3, Anna Maria Musti4
1Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy. ernestina.defrancesco@manchester.ac.uk.
Abstract:
The Notch signaling pathway acts in both physiological and pathological conditions, including embryonic development and tumorigenesis. In cancer progression, diverse mechanisms are involved in Notch-mediated biological responses, including angiogenesis and epithelial-mesenchymal-transition (EMT). During EMT, the activation of cellular programs facilitated by transcriptional repressors results in epithelial cells losing their differentiated features, like cell–cell adhesion and apical–basal polarity, whereas they gain motility. As it concerns cancer epithelial cells, EMT may be consequent to the evolution of genetic/epigenetic instability, or triggered by factors that can act within the tumor microenvironment. Following a description of the Notch signaling pathway and its major regulatory nodes, we focus on studies that have given insights into the functional interaction between Notch signaling and either hypoxia or estrogen in breast cancer cells, with a particular focus on EMT. Furthermore, we describe the role of hypoxia signaling in breast cancer cells and discuss recent evidence regarding a functional interaction between HIF-1α and GPER in both breast cancer cells and cancer-associated fibroblasts (CAFs). On the basis of these studies, we propose that a functional network between HIF-1α, GPER and Notch may integrate tumor microenvironmental cues to induce robust EMT in cancer cells. Further investigations are required in order to better understand how hypoxia and estrogen signaling may converge on Notch-mediated EMT within the context of the stroma and tumor cells interaction. However, the data discussed here may anticipate the potential benefits of further pharmacological strategies targeting breast cancer progression.
Insights
The Notch pathway, influenced by hypoxia and estrogen, drives epithelial-mesenchymal-transition (EMT) in breast cancer. Targeting this network may offer new therapeutic strategies for cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The Notch signaling pathway is crucial in development and cancer, regulating processes like angiogenesis and epithelial-mesenchymal-transition (EMT).
- EMT involves epithelial cells losing differentiation and gaining motility, contributing to cancer progression, often influenced by genetic instability or the tumor microenvironment.
Purpose of the Study:
- To explore the functional interactions between Notch signaling, hypoxia, and estrogen in breast cancer cells, focusing on EMT.
- To investigate the role of hypoxia signaling and the interaction between HIF-1α and GPER in breast cancer cells and cancer-associated fibroblasts (CAFs).
Main Methods:
- Review of studies on Notch signaling pathways and their regulatory nodes.
- Analysis of research on the interplay between Notch signaling, hypoxia, and estrogen in breast cancer.
- Examination of evidence for functional interactions between HIF-1α, GPER, and Notch signaling.
Main Results:
- Notch signaling, hypoxia, and estrogen are implicated in driving EMT in breast cancer.
- A functional interaction exists between hypoxia-inducible factor 1-alpha (HIF-1α) and G protein-coupled estrogen receptor (GPER) in breast cancer cells and CAFs.
- A proposed functional network involving HIF-1α, GPER, and Notch signaling integrates tumor microenvironmental cues to induce EMT.
Conclusions:
- The convergence of hypoxia and estrogen signaling on Notch-mediated EMT highlights a complex regulatory network.
- Further research is needed to elucidate the precise mechanisms of hypoxia and estrogen signaling in Notch-mediated EMT within the tumor microenvironment.
- The findings suggest potential benefits for pharmacological strategies targeting this network to inhibit breast cancer progression.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

